Key result
Lysophosphatidylcholine stimulation of PC12 cells resulted in 121 differentially expressed lncRNAs and 483 mRNAs, with lncRNA ENSRNOT00000082515 interacting with 626 mRNAs enriched in neurodegenerative disease pathways.
Why the study?
The biological mechanism of lysophosphatidylcholine and the expression profile of long noncoding RNAs under its stimulation had not been reported.
LPC stimulation alters the expression of specific lncRNAs and mRNAs in PC12 cells, revealing potential regulatory networks that may be involved in neuroprotection and neurodegenerative diseases.
Lysophosphatidylcholine (LPC) was previously found to show neuroprotective effect on nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF) induced signalings. Also, numerous studies reported the emerging roles of long noncoding RNAs (LncRNAs) involved in neurodegenerative disease. However, the biological mechanism of LPC and expression profile of lncRNAs has not been reported. Here, lncRNAs in PC12 cells under LPC and NGF treatment were analyzed using high throughput sequencing technology for the first time. We identified 564 annotated and 1077 novel lncRNAs in PC12 cells. Among them, 121 lncRNAs were differentially expressed in the PC12 cells under LPC stimulation. KEGG analysis showed that differentially expressed mRNAs co-expressed with lncRNAs mainly enriched in ribosome, oxidative phosphorylation, Parkinson's disease, Huntington's disease and Alzheimer's disease etc. LncRNA-mRNA network analysis showed that lncRNA ENSRNOT00000082515 had interactions with 626 different mRNAs suggesting that lncRNA ENSRNOT00000082515 probably play vital role. Finally, sequencing data were validated by qRT-PCR for ENSRNOT00000084874, ENSRNOT00000082515, LNC_001033 forward Fgf18, Vcam1, and Pck2.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied Neurodegenerative diseases (in vitro model). Lysophosphatidylcholine (LPC) and Nerve Growth Factor (NGF) vs. Untreated control was evaluated on Differentially expressed lncRNAs and mRNAs. Lysophosphatidylcholine stimulation of PC12 cells resulted in 121 differentially expressed lncRNAs and 483 mRNAs, with lncRNA ENSRNOT00000082515 interacting with 626 mRNAs enriched in neurodegenerative disease pathways.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: